Efficacy and Safety of DKB-119 in Patients in Crow's Feet

D

Dongkook Pharmaceutical

Status

Active, not recruiting

Conditions

Crow's Feet

Treatments

Device: DKB-119

Study type

Interventional

Funder types

Industry

Identifiers

NCT06021418
DKB-119-MD-2

Details and patient eligibility

About

To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety DKB-119 and control for patients in crow's feet

Full description

A single center, randomized, subject and evaluator blinded, split-face, pivotal clinical trial

Enrollment

100 patients

Sex

All

Ages

19 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those who are over 19 under 70 ages.
  • Those who score 2 or more in the LCL severity evaluation.
  • Those who have visually symmetrical crow's feet on both sides.
  • Etc.

Exclusion criteria

  • Pregnancy and lactating women.
  • Etc.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

DKB-119
Experimental group
Description:
Injecting to one side crow's feet
Treatment:
Device: DKB-119
Control
Active Comparator group
Description:
Injecting to one side crow's feet
Treatment:
Device: DKB-119

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems